Study finds higher risk of cardiovascular events among type 2 diabetes patients who discontinue GLP‑1 therapy
An observational study reported that people with type 2 diabetes who stopped GLP‑1 medication experienced about twice the rate of heart attack, stroke, or death compared with those who continued treatment. The authors…